Citizens for Medical Isotopes

We've all been touched by cancer.
Cancer is a terrible disease and we all know its devastating impact. Citizens for Medical Isotopes was founded as a non-profit organization to educate about exciting new cancer treatments that use medical isotopes. Cell targeting is the wave of the future in treating disease, and because of this ability to specifically target radioisotopes at cancer cells while minimizing exposure to healthy cells, medical isotopes can play an important role in a new revolution in cancer treatment - increased effectiveness, decreased side effects, lives saved, health regained. But we need your help.


Name
eMail*
Subject

If you would like more information about what is going on with medical isotopes with respect to promising new Cancer Treatments, fill in the form above and click on 'Submit Request'(*=required).

Medical Isotope News

May 28, 2008 Kennewick Company Researching Treatments that Could Save Ted Kennedy Key words: malignant, glioma, brain, tumor, 211At, AMIC, research, inoperable

May 24, 2008 New CMI Page - Malignant Glioma (brain tumor therapy)

May 22, 2008 Society of Nuclear Medicine explores feasibility of U.S. medical isotope source "For all intents and purposes, there is nothing, which is a sad state of affairs," Atcher said. "Most of the places that have an operating reactor do not have the processing capability in the form of hot cells and a staff that would work 24/7 toward that activity. There are some facilities that have the hot cell capability, but don't have the manpower or the reactor nearby." Local PDF

May 22, 2008 CMI Comments on malignant brian tumor therapy: Literature search reveals that several animal and phase I clinical trials are showing useful response to 131I, 213Bi, and 211At labeled treatments in certain malignant glioma situations. 131I is a beta emitter with intermediate range penetration and 213Bi and 211At are alpha emitters with short range or cell proximity effect. The latter preferred isotopes are in very limited supply and only available to select study groups.

May 17, 2008 Maple reactor development shutdown not without fallout "...The decision has immediate implications: for AECL's reputation as a seller of reliable nuclear technology sold around the world; for the 2,000-plus people in the Deep River area who work for AECL, and for Nordion's position as the producer of more than half the world's isotopes used to diagnose fractures and treat cancers. ..."

April 14, 2008 US-DOE Isotope Status Presentation 17-March-2008.
Summary:

Insufficient dedicated isotope production capabilities to permit year-round
isotope production.

Aging facilities and equipment.

Isotope research and development needs to be reestablished.

No lead sponsor for large commercial isotopes (americium-241, californium-252).

Batch pricing caused by budget restrictions is impacting research.

Researchers are forced to pay for the entire isotope batch.

No guarantee that research isotopes will be produced when requested.

Reduced isotope portfolio (FY 2002).

April 14, 2008 Eradimaging(posted January 2008):
Society of Nuclear Medicine: National Academy of Sciences Report Supports Restored Federal Funding For Nuclear Medicine Research (CMI Comment: 85% drop in 2006; data and embedded chart presented at CMI symposium.)

April 11, 2008 Tri-City Herald News
'Shuttle' may aid isotope creation at Idaho lab Lack of US production for short lived medical isotopes prompt studies to modifiy US-DOE reactor. (CMI Comment: How about considering all US reactors include medical isotope production shuttle(s)?)

March 31, 2008 Tri-City Herald Editorial
Isotope symposium keeps Tri-Cities at the forefront

Mar. 27, 2008 Tri-City Herald News
Advances in isotope science win a surprising convert

On March 26, 2008 - Mini Symposium: The Cure Starts Here!
Citizens for Medical Isotopes is pleased to announce a short symposium featuring regional and national experts in medical isotopes for diagnosis and therapy to be held March 26th at the Three Rivers Convention Center in Kennewick, Washington. Additional Information

Jan. 31, 2008 - Research - PLoS Med 3(11): e427(Nov 2006)
Medical Isotopes Show Promise in Curing HIV/AIDS The HIV epidemic is a major threat to health in the developing and western worlds. A modality that targets and kills HIV-1-infected cells could have a major impact on the treatment of acute exposure and the elimination of persistent reservoirs of infected cells. The aim of this proof-of-principle study was to demonstrate the efficacy of a therapeutic strategy of targeting and eliminating HIV-1-infected cells with radiolabeled antibodies specific to viral proteins in vitro and in vivo.

Dec. 18, 2007 - Press Release
Advanced Medical Isotope Corporation Initiates Actions to Supply Medical Isotopes to Taiwan and Mainland China

Dec. 14, 2007 - CMI staff commentary
A chronology of endorsement and isotope supply needs...

Dec. 5, 2007 - The Toronto Star
Medical Isotope Supply Interrrupted A problem with a Canadian nuclear reactor that produces medical isotopes used to diagnose and treat cancer cases has left patients in Canada and around the world in limbo...
Nov. 20, 2007 - National Academy of Sciences
Nuclear Medicine Holds Many Promises for Improved Care "Executive summary on the availability or lack thereof US medical isotope production...

Supporting Sponsors of 2008 CMI Symposium
"The Cure Starts Here!"

Advanced Medical Isotopes Corp.

Conover Insurance

Central Washington Building & Construction Council

International Brotherhood of Electrical Workers

Kestrel Vintners

National Association of Cancer Patients

Picazo House

Tri-Cities Local Business Association

Join Citizens for Medical Isotopes as we work to make sure that these treatments will be available now and in the future.

Send Us a Note(popup)
Updated:
May 24, 2008